S. Mercille et al., Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0myeloma cells transfected with the E1B-19K adenoviral gene, BIOTECH BIO, 63(5), 1999, pp. 516-528
It is now well documented that apoptosis represents the prevalent mode of d
eath in lymph old cultures and occurs spontaneously in late-exponential pha
se of batch cultures following nutrient exhaustion. In an attempt to enhanc
e the cell survival of these cell lines, we have initially engineered nonpr
oducing NS/0 myeloma cells with a vector expressing the adenoviral E1B-19K
protein. NS/0 cells transfected with E1B-19K were found to be more resistan
t to apoptosis occurring in the late phase of batch culture and under stres
sful conditions such as cultivation in glutamine-free medium or following h
eat shock. In this study, we have characterised a number of NS/0 subclones
constitutively expressing different levels of E1B-19K, as well as several s
ubclones in which the expression of E1B-19K was regulated by a tetracycline
-controllable gene switch. We have found that a threshold E1B-19K level was
required in order to achieve protection against apoptosis. The extent of r
esistance against cell death induced by nutrient deprivation in glutamine-f
ree medium and in the late phase of batch cultures correlated with the leve
l of E1B-19K expression up to an optimal level where further increases in E
1B-19K levels did not result in significant additional protection. To asses
s the effects of E1B-19SK on antibody productivity, an apoptosis-resistant
NS/0 clone was then transfected with a chimeric antibody construct. Despite
their improved viability, the antibody productivity of E1B-19K clones in b
atch culture was not significantly improved. Moreover, while the use of E1B
-19K considerably delayed cell death, cells eventually died by apoptosis. S
urprisingly, E1B-19K had no beneficial effect on the efficiency of fusion o
f NS/0 myelomas and splenocytes for the generation of hybridoma cells. Furt
hermore, the resulting hybridomas, although expressing E1B-19K at levels co
mparable to the myeloma parent, were no longer resistant to apoptosis. This
indicates that the ability of E1B-19K to prevent apoptosis is not only dos
e-dependent but also seems to be cell-type dependent. (C) 1999 John Wiley &
Sons, Inc.